We're looking at that vaccine and it is a single antigen vaccine. And for respiratory illnesses, the single antigen vaccines have never worked. So it's not because of lack of personnel or lack of. I mean, We are actually shifting our priorities to multiple antigen vaccines. And NIH is already working on a number of those. So that's the answer to that. I get that. Last week you said 20% of those fired were by mistake and you knew that was going to happen, right? (14:58–15:06)
CLAIM
Asserts a shift in priority to multiple antigen vaccines, with NIH already working on them.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.